InsiderSignal.AI

InsiderSignal.ai

CARL - Carlsmed, Inc.

Insider Purchase by Root Jonathan D (Dir)

1 Year
After Trade
Before Trade

Loading data...

Trade Summary

7 months ago, Root Jonathan D, serving as Dir at Carlsmed, Inc. (CARL), purchased 466,666 shares at $15.00 per share, for a total transaction value of $6,999,990.00. Following this transaction, Root Jonathan D now holds 1,601,742 shares of CARL.

This purchase represents a 41.00% increase in Root Jonathan D's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Thursday, July 24, 2025 and publicly disclosed via SEC Form 4 filing on Thursday, July 24, 2025, meaning the disclosure happened on the same day as the trade.

Carlsmed, Inc. operates in the HEALTHCARE sector, specifically within the HEALTH INFORMATION SERVICES industry. Insider buying activity in this sector can provide valuable signals about industry trends and company-specific developments.

Root Jonathan D

Dir

Jonathan D. Root, M.D., M.B.A. is an Independent Director and Chair of the Nominating and Corporate Governance Committee on the Board of Directors at Carlsmed, Inc. (CARL), where he has recently engaged in insider trading activities and holds approximately 6,126,072 shares valued over $78 million.[[1]](https://carlsmed.com/company/)[[2]](https://www.gurufocus.com/insider/32953/jonathan-d-root) A General Partner at U.S. Venture Partners (USVP) since 1997, after joining as a Ewing Marion Kauffman Fellow in 1995, Root brings extensive experience in healthcare venture capital, currently serving on boards including Edgewise Therapeutics, Inari Medical, HealthJoy, Okami Medical, Omada Health, Nuvaira, Ribon Therapeutics, Route 92 Medical, and Sparrow Pharmaceuticals, among others.[[1]](https://carlsmed.com/company/)[[3]](https://www.missionbaycapital.com/jonathan-root)[[5]](https://edgewisetx.com/team/jon-root-m-d/)[[6]](https://www.usvp.com/team/jon-root/) Prior to venture capital, Dr. Root was Assistant Professor of Neurology and Director of the Neurology-Neurosurgery Special Care Unit (or Intensive Care Unit) at New York Hospital-Cornell Medical Center, and he is board certified in neurology.[[1]](https://carlsmed.com/company/)[[3]](https://www.missionbaycapital.com/jonathan-root)[[5]](https://edgewisetx.com/team/jon-root-m-d/) His career highlights include leading USVP investments in companies such as Castlight Health, Lutonix, MicroVention, Proteolix, and Sequent Medical.[[3]](https://www.missionbaycapital.com/jonathan-root) Root holds an A.B. in Economics from Dartmouth College, an M.D. from the University of Florida College of Medicine, and an M.B.A. from Columbia University.[[1]](https://carlsmed.com/company/)[[3]](https://www.missionbaycapital.com/jonathan-root)[[5]](https://edgewisetx.com/team/jon-root-m-d/)

View full insider profile →

Trade Price

$15.00

Quantity

466,666

Total Value

$6,999,990.00

Shares Owned

1,601,742

Trade Date

Thursday, July 24, 2025

213 days ago

SEC Filing Date

Thursday, July 24, 2025

HEALTHCAREHEALTH INFORMATION SERVICES

About Carlsmed, Inc.

Company Overview

No company information available
View news mentioning CARL

💬 Want Deeper Insight?

Use our AI assistant to ask questions about this trade, the insider, or the company.

Chat with AI

Share this trade

https://insidersignal.ai/trade/85998

🚀 Track Insider Trades in Real-Time

Create a free account to access our full database of insider trades, AI-powered analysis, price alerts, and discover what corporate executives are buying and selling.

Create Free AccountLearn More

✓ Free forever plan available  •  ✓ No credit card required  •  ✓ Cancel anytime